Mayne Pharma | Les Charges D'Exploitation



Operating Expenses Changement Date
Ansell USD 358.55M 386.85M 2024-06
Avita Medical AUD 28.36M 2.44M 2024-12
Cochlear AUD 917M 73.4M 2024-06
CSL USD 5.55B 108M 2024-06
Ecofibre AUD 12.31M 44.07M 2024-06
Healius AUD 684.9M 261.2M 2024-12
Integral Diagnostics AUD 219.16M 66.76M 2024-06
Medical Developments International AUD 10.35M 17.73M 2024-06
Nanosonics AUD 42.61M 34M 2024-06
Next Science USD 17.1M 2.67M 2024-06
Polynovo AUD 27.51M 19.08M 2024-06
Ramsay Health Care AUD 8.35B 258.6M 2024-12
ResMed USD 864.85M 27.65M 2024-12
Sigma Healthcare AUD 1.87B 192.57M 2024-07
Sonic Healthcare AUD 4.23B 2.14B 2024-12
Telix Pharmaceuticals AUD 321.98M 62.28M 2024-06



Mayne Pharma Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.